Change history
10 April 2014
In the version of this article initially published, the corresponding author was given in the HTML as Z.-Y. Wang, rather than the H.-Y. Zhang. The error has been corrected in the HTML version of the article.
References
Andronis, C., Sharma, A., Virvilis, V., Deftereos, S. & Persidis, A. Brief. Bioinform. 12, 357–368 (2011).
Iorio, F. et al. Proc. Natl. Acad. Sci. USA 107, 14621–14626 (2010).
Dudley, J.T., Deshpande, T. & Butte, A.J. Brief. Bioinform. 12, 303–311 (2011).
Sanseau, P. et al. Nat. Biotechnol. 30, 317–320 (2012).
Wang, Z.Y., Fu, L.Y. & Zhang, H.Y. Trends Mol. Med. 18, 69–71 (2012).
Brinkman, R.R., Dubé, M.P., Rouleau, G.A., Orr, A.C. & Samuels, M.E. Nat. Rev. Genet. 7, 249–260 (2006).
Lowe, C.E. et al. Nat. Genet. 39, 1074–1082 (2007).
Mallareddy, M., Hanes, V. & White, W.B. Drugs Aging 24, 453–466 (2007).
Lim, P.O. et al. Hypertension 37, 856–861 (2001).
Chopra, P., Randhawa, I. & Chin, T. Current Drug Ther. (NY) 7, 30–35 (2012).
Dong, Y.F. et al. FASEB J. 25, 2911–2920 (2011).
Gann, P.H., Hennekens, C.H., Ma, J., Longcope, C. & Stampfer, M.J. J. Natl. Cancer Inst. 88, 1118–1126 (1996).
van der Lely, A.J. et al. Lancet 358, 1754–1759 (2001).
Sekine, K. et al. Endocrinol. Jpn. 29, 653–657 (1982).
Acknowledgements
This work was supported by the National Basic Research Program of China (973 project, grants 2010CB126100 and 2012CB721000), the National Natural Science Foundation of China (grant 21173092) and the Fundamental Research Funds for the Central Universities (grants 2011PY142 and 2011PY027).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Supplementary Table 1 (XLS 63 kb)
Supplementary Table 2
Supplementary Table 2 (XLS 185 kb)
Rights and permissions
About this article
Cite this article
Wang, ZY., Zhang, HY. Rational drug repositioning by medical genetics. Nat Biotechnol 31, 1080–1082 (2013). https://doi.org/10.1038/nbt.2758
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2758
- Springer Nature America, Inc.
This article is cited by
-
In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
BMC Bioinformatics (2021)
-
The tumor therapy landscape of synthetic lethality
Nature Communications (2021)
-
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
Molecular Medicine (2019)
-
DR2DI: a powerful computational tool for predicting novel drug-disease associations
Journal of Computer-Aided Molecular Design (2018)
-
Drug enrichment and discovery from schizophrenia genome-wide association results: an analysis and visualisation approach
Scientific Reports (2017)